Effect of Resistant Starch (Type-4) on Metabolic Syndrome
Dietary Fiber Intervention in Hutterite Population of South Dakota With and Without Signs of Metabolic Syndrome
1 other identifier
interventional
86
1 country
1
Brief Summary
Metabolic syndrome is a condition characterized by excess body weight, large waist circumference, high cholesterol and glucose in the blood, and hypertension. People with metabolic syndrome are at increased risk for heart diseases. Research shows benefits of regular fiber intake in metabolic syndrome. However, due to altered taste and texture of the high fiber foods, long term intake of fiber is a challenge for metabolic syndrome patients. This study is designed to find if blinded-substitution of regular wheat flour in domestic kitchen with wheat flour enriched by an adaptable type of fiber (resistant starch-4), minimizes metabolic syndrome symptoms. this special type of fiber is also obtained from wheat.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for not_applicable
Started Mar 2012
Shorter than P25 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
October 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
October 1, 2012
CompletedFirst Submitted
Initial submission to the registry
June 20, 2013
CompletedFirst Posted
Study publicly available on registry
June 27, 2013
CompletedSeptember 27, 2021
September 1, 2021
7 months
June 20, 2013
September 21, 2021
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Changes in metabolic syndrome risk components
26 weeks
Secondary Outcomes (3)
Changes in anthropometric outcomes
26 weeks
Changes in blood lipid profile
26 weeks
Changes in blood glucose indices
26 weeks
Study Arms (2)
Community-1
OTHERReceived control flour first and then Resistant starch type 4 (RS4) flour
Community-2
OTHERReceived RS4 flour first and then control flour
Interventions
Eligibility Criteria
You may qualify if:
- \- Any individual aged 18-80 years
You may not qualify if:
- Pregnant
- Lactating
- Requires special diets or dietary regimens
- On long term antibiotic therapy
- Diagnosed with gastrointestinal diseases (Irritable Bowel syndrome, Crohn's disease or Colitis)
- Immune compromised
- Have cancer
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
South Dakota State University
Brookings, South Dakota, 57007, United States
Related Publications (1)
Dhakal S, Dey M. Resistant starch type-4 intake alters circulating bile acids in human subjects. Front Nutr. 2022 Oct 20;9:930414. doi: 10.3389/fnut.2022.930414. eCollection 2022.
PMID: 36337613DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Moul Dey, PhD
South Dakota State University
- PRINCIPAL INVESTIGATOR
Bonny Specker, PhD
South Dakota State University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- DOUBLE
- Who Masked
- PARTICIPANT, INVESTIGATOR
- Purpose
- PREVENTION
- Intervention Model
- CROSSOVER
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Associate Professor
Study Record Dates
First Submitted
June 20, 2013
First Posted
June 27, 2013
Study Start
March 1, 2012
Primary Completion
October 1, 2012
Study Completion
October 1, 2012
Last Updated
September 27, 2021
Record last verified: 2021-09
Data Sharing
- IPD Sharing
- Will not share
Individual participant's identity will not be shared. This clinical trial is complete. All results were published as two research articles: PMCID: PMC4928084 and PMCID: PMC4048643. Raw sequence data were submitted to Sequence Read archive as referenced in the manuscript PMC4928084.